Using “cure” to refer to “obtaining a normal life” also fits — if you ignore previously lost education, career opportunities ...

Growing advancements in haemophilia treatment underscore a significant shift toward targeted and long-lasting therapeutic solutions. Innovations such as gene therapy, extended half-life clotting ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

The global prothrombin complex concentrates market is on a strong upward trajectory, with projections indicating substantial growth in the coming decade. According to a recent report by Future Market ...

Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%< ...

Refacto Market Report 2025 - Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 The Business Research Company's ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

MacDonald wonders what format a reality TV show might take to best capture the lives of people with hemophilia.

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Developed by CSIR’s National Institute for Interdisciplinary Science and Technology (NIIST), the "Sṝrjanam" rig represents a ...

U.S. President Donald Trump’s threats to slap tariffs on medicines could rattle an industry that has become a cornerstone of ...

Science & Technology; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh  today inaugurated the 4-day International Conference on Governance dedicated to the ...